Stockscreener 앱 받기
54.78
1.51%
-0.84
전일 마감가:
$55.62
열려 있는:
$55.3
하루 거래량:
342.55K
Relative Volume:
0.35
시가총액:
$2.97B
수익:
$199.84M
순이익/손실:
$-100.06M
주가수익비율:
-28.09
EPS:
-1.95
순현금흐름:
$-103.57M
1주 성능:
+1.14%
1개월 성능:
+6.93%
6개월 성능:
-42.61%
1년 성능:
-14.82%
1일 변동 폭
$53.97
$55.30
1주일 범위
$52.30
$56.63
52주 변동 폭
$47.04
$103.81
Procept Biorobotics Corp Stock (PRCT) Company Profile
명칭
Procept Biorobotics Corp
전화
(650) 232-9832
주소
150 BAYTECH DRIVE, SAN JOSE
PRCT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
54.80 | 2.97B | 199.84M | -100.06M | -103.57M | -1.95 |
|
ABT
Abbott Laboratories
|
132.30 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.57 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.57 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.44 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.41 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-02 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 개시 | Jefferies | Hold |
| 2023-08-11 | 개시 | Piper Sandler | Overweight |
| 2023-05-31 | 개시 | William Blair | Outperform |
| 2022-10-31 | 개시 | BTIG Research | Neutral |
| 2022-10-25 | 개시 | Truist | Buy |
| 2022-09-02 | 개시 | Wells Fargo | Overweight |
| 2022-07-15 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | 개시 | B. Riley Securities | Buy |
| 2021-10-11 | 개시 | BofA Securities | Buy |
| 2021-10-11 | 개시 | Cowen | Outperform |
| 2021-10-11 | 개시 | Goldman | Neutral |
| 2021-10-11 | 개시 | Guggenheim | Buy |
| 2021-10-11 | 개시 | SVB Leerink | Outperform |
모두보기
Procept Biorobotics Corp 주식(PRCT)의 최신 뉴스
Procept BioRobotics Corp (PRCT) expanding its growth trajectory ahead - Sete News
Leerink Partnrs Has Negative Outlook of PRCT Q2 Earnings - Defense World
Market Insight: Procept BioRobotics Corp (PRCT)’s Notable Drop, Closing at 53.98 - DWinneX
William Blair Issues Pessimistic Forecast for PRCT Earnings - Defense World
Did Procept BioRobotics Corp (PRCT) perform well in the last session? - uspostnews.com
Mariner LLC Purchases 2,429 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
PROCEPT BioRobotics Leadership to Present at Four Premier Healthcare Investment Conferences - Stock Titan
Leerink cuts Procept BioRobotics price target to $90, keeps outperform By Investing.com - Investing.com Nigeria
Promising Potential of PROCEPT BioRobotics’ Aquablation Technology in Prostate Cancer Treatment Drives Buy Rating - TipRanks
Leerink cuts Procept BioRobotics price target to $90, keeps outperform - Investing.com
Bank of America Cuts PROCEPT BioRobotics (NASDAQ:PRCT) Price Target to $84.00 - Defense World
Procept BioRobotics Corp [PRCT] Records 50-Day SMA of $58.96 - knoxdaily.com
Procept BioRobotics price target lowered to $84 from $104 at BofA - TipRanks
Closing Figures: Procept BioRobotics Corp (PRCT)’s Negative Finish at 52.56, Down -5.64 - DWinneX
Procept BioRobotics Corp [PRCT] stock Initiated by Morgan Stanley analyst, price target now $105 - dbtnews.com
Where PROCEPT BioRobotics Stands With Analysts - Benzinga
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2025 Earnings Call Transcript - Insider Monkey
Procept BioRobotics (PRCT) Target Price Cut to $84 by BofA Analy - GuruFocus
Procept BioRobotics reports Q1 EPS (45c), consensus (49c) - TipRanks
PROCEPT BioRobotics (NASDAQ:PRCT) Sees Large Volume Increase on Earnings Beat - Defense World
PROCEPT BioRobotics Sees Strong Revenue Growth in Q1 2025 - TipRanks
Earnings call transcript: Procept Biorobotics beats Q1 2025 EPS forecast By Investing.com - Investing.com India
Procept Biorobotics Corp. Reports Strong Q1 Growth Amid Challenges - TipRanks
Procept BioRobotics sees FY25 revenue $323M, consensus $321.67M - TipRanks
Breakthrough BPH Treatment: Experts Reveal Long-Term Aquablation Results at Major Urology Conference - Stock Titan
Morgan Stanley lowers Procept BioRobotics price target, sees buying opportunity - TipRanks
Procept BioRobotics Corp’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - investchronicle.com
PROCEPT BioRobotics (PRCT) Sees Significant Revenue Growth in Q1 2025 - GuruFocus
Procept BioRobotics Corp (NASDAQ:PRCT): It’s all about numbers this morning - uspostnews.com
Nothing is Better Than Procept BioRobotics Corp (PRCT) stock at the moment - Sete News
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates - MSN
Earnings call transcript: Procept Biorobotics beats Q1 2025 EPS forecast - Investing.com
Procept Biorobotics earnings beat by $0.04, revenue topped estimates - Investing.com
Why Procept Biorobotics Shares Are Under Pressure - TipRanks
PROCEPT BioRobotics Reports First Quarter 2025 Financial Results - TradingView
12-Month Price Target For Procept BioRobotics Corp (NASDAQ:PRCT) Now Sits At 105 - Marketing Sentinel
PROCEPT Crushes Q1 Expectations: 55% Revenue Growth, International Sales Double, 2025 Guidance Raised - Stock Titan
LPL Financial LLC Boosts Stake in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Shares Sold by Wells Fargo & Company MN - Defense World
Piper Sandler maintains $100 target on Procept BioRobotics stock By Investing.com - Investing.com Canada
Piper Sandler maintains $100 target on Procept BioRobotics stock - Investing.com Australia
Analysts Set PROCEPT BioRobotics Co. (NASDAQ:PRCT) PT at $91.43 - Defense World
Truist Financial Cuts PROCEPT BioRobotics (NASDAQ:PRCT) Price Target to $70.00 - Defense World
Leading Urologists Join PROCEPT BioRobotics Leadership for Exclusive Investor Insights - Stock Titan
JPMorgan Chase & Co. Lowers Stock Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Vanguard Group Inc. Purchases 297,075 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Corebridge Financial Inc. Sells 496 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Raymond James Financial Inc. Purchases Shares of 20,453 PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
HighTower Advisors LLC Buys 1,026 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Sei Investments Co. Grows Stake in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Teacher Retirement System of Texas Takes Position in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Procept Biorobotics Corp (PRCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10.27%
0.08%
자본화:
|
볼륨(24시간):